These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36804543)

  • 21. Brazilein Suppresses Inflammation through Inactivation of IRAK4-NF-κB Pathway in LPS-Induced Raw264.7 Macrophage Cells.
    Kim KJ; Yoon KY; Yoon HS; Oh SR; Lee BY
    Int J Mol Sci; 2015 Nov; 16(11):27589-98. PubMed ID: 26593910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling.
    Wu J; Zhang YY; Guo L; Li H; Chen DF
    PLoS One; 2013; 8(10):e78051. PubMed ID: 24167596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).
    Dunne A; Carpenter S; Brikos C; Gray P; Strelow A; Wesche H; Morrice N; O'Neill LA
    J Biol Chem; 2010 Jun; 285(24):18276-82. PubMed ID: 20400509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular HSP90α Induces MyD88-IRAK Complex-Associated IKKα/β-NF-κB/IRF3 and JAK2/TYK2-STAT-3 Signaling in Macrophages for Tumor-Promoting M2-Polarization.
    Fan CS; Chen CC; Chen LL; Chua KV; Hung HC; Hsu JT; Huang TS
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.
    Shi M; Deng Y; Yu H; Xu L; Shi C; Chen J; Li G; Du Y; Wang YG
    Mediators Inflamm; 2019; 2019():7634761. PubMed ID: 31611735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moesin-induced signaling in response to lipopolysaccharide in macrophages.
    Zawawi KH; Kantarci A; Schulze-Späte U; Fujita T; Batista EL; Amar S; Van Dyke TE
    J Periodontal Res; 2010 Oct; 45(5):589-601. PubMed ID: 20546116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway.
    Kim KA; Lee IA; Gu W; Hyam SR; Kim DH
    Mol Nutr Food Res; 2014 May; 58(5):963-72. PubMed ID: 24402767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
    Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
    Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear factor translocation and acute anterior uveitis.
    Wang J; Lu H; Hu X; Chen W; Xu Z; Li S; Xu Y
    Mol Vis; 2011 Jan; 17():170-6. PubMed ID: 21264236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
    Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
    J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSTMP Exerts Anti-Inflammatory Effects on LPS-Induced Human Renal Proximal Tubular Epithelial Cells by Inhibiting TLR4-Mediated NF-κB Pathways.
    Ding Y; Liao W; He X; Xiang W; Lu Q
    Inflammation; 2016 Apr; 39(2):849-59. PubMed ID: 26956469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
    Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
    J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD163+ M2 Macrophages Promote Fibrosis in IgG4-Related Disease Via Toll-like Receptor 7/Interleukin-1 Receptor-Associated Kinase 4/NF-κB Signaling.
    Chinju A; Moriyama M; Kakizoe-Ishiguro N; Chen H; Miyahara Y; Haque ASMR; Furusho K; Sakamoto M; Kai K; Kibe K; Hatakeyama-Furukawa S; Ito-Ohta M; Maehara T; Nakamura S
    Arthritis Rheumatol; 2022 May; 74(5):892-901. PubMed ID: 34907668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE
    Wu X; Xu M; Liu Z; Zhang Z; Liu Y; Luo S; Zheng X; Little PJ; Xu S; Weng J
    Pharmacol Res; 2022 Jan; 175():106043. PubMed ID: 34954030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation.
    Mirza MK; Yuan J; Gao XP; Garrean S; Brovkovych V; Malik AB; Tiruppathi C; Zhao YY
    Am J Pathol; 2010 May; 176(5):2344-51. PubMed ID: 20304961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
    Joh EH; Jeong JJ; Kim DH
    Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice.
    Bi W; Cheng X; Zeng Z; Zhou R; Luo R; Zhang J; Zhu L
    Neurol Res; 2021 May; 43(5):358-371. PubMed ID: 33749522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
    Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
    Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
    Noman AS; Koide N; Hassan F; I-E-Khuda I; Dagvadorj J; Tumurkhuu G; Islam S; Naiki Y; Yoshida T; Yokochi T
    Innate Immun; 2009 Feb; 15(1):33-41. PubMed ID: 19201823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.